Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A

    Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A

    FromCell & Gene: The Podcast

    Start listeningView podcast show

    Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A

    FromCell & Gene: The Podcast

    ratings:
    Length:
    20 minutes
    Released:
    Sep 30, 2021
    Format:
    Podcast episode

    Description

    Spark Therapeutics' Clinical Development Lead, Hematology, Dr. Tiffany Chang explains the company's data from its ongoing Phase 1/2 clinical trial of investigational SPK-8011 for hemophilia A, the largest gene therapy trial in this disease to date as well as the misconceptions and unknowns about the disease.
    Released:
    Sep 30, 2021
    Format:
    Podcast episode

    Titles in the series (76)

    Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.